3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
13
Esophageal Squamous Cell Carcinoma
7
Rectal Neoplasms
4
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
HER2-positive Breast Cancer
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Turcot syndrome
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of External Auditory Canal
1
Seminoma
1
Recurrence
1
Pathologic Complete Response
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Interventions
lenvatinib
2
atezolizumab
2
Bevacizumab
2
Antibodies
2
sintilimab
1
pembrolizumab
1
camrelizumab
1
User-Centered Design
1
Standard of Care
1
Neuropsychological Tests
1
Neoadjuvant Therapy
1
Liver Transplantation
1
Lead
1
Injections
1
Control Groups
1
Catheter Ablation
1
Adjuvants, Pharmaceutic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Liver Diseases
×
Neoadjuvant Therapy
×
Clear all
NCT04727307
2025-09-30
AB-LATE02
University Hospital, Montpellier
Phase 2
Recruiting
202 enrolled